P & G Health Ltd

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE199A01012
  • NSEID: PGHL
  • BSEID: 500126
INR
6,325.00
83.9 (1.34%)
BSENSE

Jun 18

BSE+NSE Vol: 10.15 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
SPARC
Marksans Pharma
Sanofi Consumer
Akums Drugs
Corona Remedies
Sudeep Pharma
Viyash Scientifi
Strides Pharma
Shilpa Medicare
P & G Health Ltd
Blue Jet Health
Why is Procter & Gamble Health Ltd ?
1
High Management Efficiency with a high ROE of 36.14%
2
Company has a low Debt to Equity ratio (avg) at 0 times
3
Poor long term growth as Net Sales has grown by an annual rate of 8.78% and Operating profit at 14.53% over the last 5 years
4
Positive results in Mar 26
  • ROCE(HY) Highest at 65.27%
  • PBDIT(Q) Highest at Rs 135.59 cr.
  • PBT LESS OI(Q) Highest at Rs 129.21 cr.
5
Technical trend is Sideways signifying no clear price momentum
  • The technical trend has deteriorated from Mildly Bullish on 08-Jun-26 and has generated 2.38% returns since then
6
With ROE of 52.8, it has a Very Expensive valuation with a 16.6 Price to Book Value
  • The stock is trading at a discount compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of 6.17%, its profits have risen by 22.9% ; the PEG ratio of the company is 1.4
7
Falling Participation by Institutional Investors
  • Institutional investors have decreased their stake by -0.94% over the previous quarter and collectively hold 19.87% of the company
  • These investors have better capability and resources to analyse fundamentals of companies than most retail investors
stock-recommendationReal-Time Research Report
Verdict Report
How much should you hold?
  1. Overall Portfolio exposure to P & G Health Ltd should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is P & G Health Ltd for you?

Medium Risk, High Return

Absolute
Risk Adjusted
Volatility
P & G Health Ltd
6.17%
0.25
24.92%
Sensex
-4.95%
-0.37
13.26%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
8.78%
EBIT Growth (5y)
14.53%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.45
Sales to Capital Employed (avg)
1.80
Tax Ratio
27.33%
Dividend Payout Ratio
88.52%
Pledged Shares
0
Institutional Holding
19.87%
ROCE (avg)
87.52%
ROE (avg)
36.14%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
32
Industry P/E
34
Price to Book Value
16.63
EV to EBIT
23.16
EV to EBITDA
21.96
EV to Capital Employed
29.52
EV to Sales
7.12
PEG Ratio
1.38
Dividend Yield
3.30%
ROCE (Latest)
115.53%
ROE (Latest)
52.75%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bearish
RSI
Bearish
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
No Trend
Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

10What is working for the Company
ROCE(HY)

Highest at 65.27%

PBDIT(Q)

Highest at Rs 135.59 cr.

PBT LESS OI(Q)

Highest at Rs 129.21 cr.

PAT(Q)

Highest at Rs 94.60 cr.

EPS(Q)

Highest at Rs 56.99

0What is not working for the Company
Icon
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for P & G Health Ltd
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 129.21 cr has Grown at 71.32%
Year on Year (YoY)
MOJO Watch
Near term PBT trend is very positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
At Rs 94.60 cr has Grown at 54.6%
Year on Year (YoY)
MOJO Watch
Near term PAT trend is very positive

PAT (Rs Cr)

Operating Profit (PBDIT) - Quarterly
Highest at Rs 135.59 cr.
in the last five quarters
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (Rs Cr)

Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 129.21 cr.
in the last five quarters
MOJO Watch
Near term PBT trend is positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
Highest at Rs 94.60 cr.
in the last five quarters
MOJO Watch
Near term PAT trend is positive

PAT (Rs Cr)

Earnings per Share (EPS) - Quarterly
Highest at Rs 56.99
in the last five quarters
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (Rs)